Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fusion protein or fusion polypeptide
Reexamination Certificate
2005-12-13
2005-12-13
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fusion protein or fusion polypeptide
C424S205100, C435S069100
Reexamination Certificate
active
06974575
ABSTRACT:
The present invention provides genetically engineered type I/type II hybrid BVDV viruses. The hybrid viruses, as well as the hybrid viral genome, can be used in immunogenic compositions and vaccines for protecting cattle from BVDV infection.
REFERENCES:
patent: 6001613 (1999-12-01), Donis et al.
Ventzislav et al, Journal of Virology, Jan. 1997, vol. 71, No. 1, pp. 471-478.
Donis R.O. et al., “Differences in Virus-Induced Polypeptides in Cells Infected by Cytopathic and Noncytopathic Biotypes of Bovine Virus Diarrhea-Mucosal Disease Virus”,Virology 158:168-173 (1987).
Collett M.S. et al., “Molecular Cloning and Nucleotide Sequence of the Pestivirus Bovine Viral Diarrhea Virus”,Virology 165:191-199 (1988).
Bolin S.R. et al., “Range of Viral Neutralizing Activity and Molecular Specificity of Antibodies Induced in Cattle by Inactivated Bovine Viral Diarrhea Virus Vaccines”,American Journal of Veterinary Research 51(5):703-707 (1990).
Howard C.J. et al., “Immunity to Bovine Virus Diarrhea Virus in Calves: The Role of Different T-Cell Subpopulations Analysed by Specific Depletion In Vivo with Monoclonal Antibodies”,Veterinary Immunology and Immunopathology 32:303-314 (1992).
Larsson B. et al., “Bovine Virus Diarrhoea Virus Induces In Vitro a Proliferative Response of Peripheral Blood Mononuclear Cells from Cattle Immunized by Infection”,Veterinary Microbiology 31:317-325 (1992).
Wiskerchen M. et al., “Pestivirus Gene Expression: Protein p80 of Bovine Viral Diarrhea Virus is a Proteinase Involved in Polyprotein Processing”,Virology 184:341-350 (1991).
Tillmann R. et al., “Processing of the Envelope Glycoproteins of Pestiviruses”,Journal of Virology 67(6):3288-3294 (1993).
Elbers K. et al., “Processing in the Pestivirus E2-NS2 Region: Indentification of Proteins p7 and E2p7”,Journal of Virology 70(6):4131-4135 (1996).
Tautz N. et al., “Serine Protease of Pestiviruses: Determination of Cleavage Sites”,Journal of Virology 71(7):5415-5422 (1997).
Ernesto J.X. et al., “Bovine Viral Diarrhea Virus NS3 Serine Proteinase: Polyprotein Cleavage Sites, Cofactor Requirements, and Molecular Model of an Enzyme Essential for Pestivirus Replication”,Journal of Virology 71(7):5312-5322 (1997).
Beer M. et al., “Cytotoxic T-Lymphocyte Responses in Cattle Infected with Bovine Viral Diarrhea Virus”,Veterinary Microbiology 58:9-22 (1997).
Lambot M. et al., “Characterization of the Immune Response of Cattle Against Non-Cytopathic and Cytopathic Biotypes of Bovine Viral Diarrhoea Virus”,Journal of General Virology 78:1041-1047 (1997).
Cao Xuemei
Zybarth Gabriele M.
Pfizer Inc.
Pfizer Products Inc.
Salimi Ali R.
Scully, Scott, Murphy & Pressser
LandOfFree
Generation of type I/type II hybrid form of bovine viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Generation of type I/type II hybrid form of bovine viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation of type I/type II hybrid form of bovine viral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3523117